What does MEDLINX LINA do?

MEDLINX LINA is a pharmacy in Schaarbeek. Private Limited, started on 23 May 2018, 1 establishment.

What is the address of MEDLINX LINA?

The registered office of MEDLINX LINA is located at Anatole Francestraat 100, 1030 Schaarbeek.

Is MEDLINX LINA still active?

Yes. According to the CBE (3 October 2026) MEDLINX LINA is active, legal situation “Normale toestand”, started on 23 May 2018.

Is MEDLINX LINA registered on Peppol?

Yes, MEDLINX LINA is registered on the Peppol network with ID 0208:0696701906.

What is the enterprise number of MEDLINX LINA?

The enterprise number of MEDLINX LINA is BE0696701906.

When was MEDLINX LINA founded?

MEDLINX LINA was founded on 23 May 2018.

Who are the directors of MEDLINX LINA?

According to the 2025 annual accounts, the directors of MEDLINX LINA are: SAID BAZGOURI.

Is MEDLINX LINA a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 23 May 2018; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did MEDLINX LINA make in 2025?

MEDLINX LINA posted a profit after taxes of € 14,170 in financial year 2025.

What is the revenue of MEDLINX LINA?

As a small company, MEDLINX LINA is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 42,645.

MEDLINX LINA (Private Limited) - Schaarbeek

Dossier MEDLINX LINA, printed on 3 October 2026 from databakkes.be/en/0696701906/medlinx-lina. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Tight liquidity NBB

Cash and receivables cover 58 % of short-term debt in 2025; threshold 65 %.

Financials

Financial year 2025

MEDLINX LINA from Schaarbeek, company number BE0696701906, closed financial year 2025 with a result of € 14,170 after tax. For that financial year MEDLINX LINA recorded a gross margin of € 42,645 and equity of € 21,969. Compared with financial year 2024, the result moved from € 22,776 to € 14,170. The company is profitable. The company holds a healthy buffer. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on June 25, 2026.

What it is worth Healthy

€ 21,969

▼ 21% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 14,170

▼ 38% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 20,274

▲ 14% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 20,000 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Wage cost estimate Staff cost at a one-person company Staff Only people on the payroll count here.€ 7,300 Likely the director’s social contribution or pension premium.The director’s pay Already netted into the gross margin, not shown separately in the accounts. Typical for one-person companies € 45,000 gross per year minimum for the reduced tax rate≈ € 2,100 net per month after contributions, tax and usually some benefits in kind, roughly Assumption based on the chart of accounts, not a figure from the source.

€ 7,300

▼ 15% vs 2024

No payroll staff. An amount this small is usually a social contribution or pension premium for the director, booked under staff costs.

Vehicles and equipment

€ 805

▼ 34% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 2 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 40,645

▼ 28% vs 2024

€ 17,339 is repaid this year. At this pace the long-term loan is gone in ≈ 2 years.

Owed to suppliers

€ 40,339

▼ 10% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 6,690

▼ 7% vs 2024

Taxes, VAT and social contributions still to pay.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 33,770 Gross margin 2022: € 33,770 First fiscal year in the series	€ 30,941 Gross margin 2023: € 30,941 ▼ 8% vs 2022 (€ 33,770) Unfavourable step	€ 56,010 Gross margin 2024: € 56,010 ▲ 81% vs 2023 (€ 30,941) Favourable step	€ 42,645 Gross margin 2025: € 42,645 ▼ 24% vs 2024 (€ 56,010) Unfavourable step	▼ 24%
Profit after taxes	€ -1,210 Profit after taxes 2022: € -1,210 First fiscal year in the series	€ -3,462 Profit after taxes 2023: € -3,462 ▼ € 2,252 vs 2022 (€ -1,210) Unfavourable step	€ 22,776 Profit after taxes 2024: € 22,776 ▲ € 26,238 vs 2023 (€ -3,462) Favourable step	€ 14,170 Profit after taxes 2025: € 14,170 ▼ 38% vs 2024 (€ 22,776) Unfavourable step	▼ 38%
Equity	€ 18,486 Equity 2022: € 18,486 First fiscal year in the series	€ 15,024 Equity 2023: € 15,024 ▼ 19% vs 2022 (€ 18,486) Unfavourable step	€ 27,800 Equity 2024: € 27,800 ▲ 85% vs 2023 (€ 15,024) Favourable step	€ 21,969 Equity 2025: € 21,969 ▼ 21% vs 2024 (€ 27,800) Unfavourable step	▼ 21%
Total debts	€ 158,472 Total debts 2022: € 158,472 First fiscal year in the series	€ 134,851 Total debts 2023: € 134,851 ▼ 15% vs 2022 (€ 158,472) Favourable step	€ 118,522 Total debts 2024: € 118,522 ▼ 12% vs 2023 (€ 134,851) Favourable step	€ 108,276 Total debts 2025: € 108,276 ▼ 9% vs 2024 (€ 118,522) Favourable step	▼ 9%
Cash	€ 41,093 Cash 2022: € 41,093 First fiscal year in the series	€ 25,950 Cash 2023: € 25,950 ▼ 37% vs 2022 (€ 41,093) Unfavourable step	€ 17,805 Cash 2024: € 17,805 ▼ 31% vs 2023 (€ 25,950) Unfavourable step	€ 20,274 Cash 2025: € 20,274 ▲ 14% vs 2024 (€ 17,805) Favourable step	▲ 14%
Land & buildings	€ 2,671 Land & buildings 2022: € 2,671 First fiscal year in the series	€ 2,331 Land & buildings 2023: € 2,331 ▼ 13% vs 2022 (€ 2,671) Unchanged	€ 1,991 Land & buildings 2024: € 1,991 ▼ 15% vs 2023 (€ 2,331) Unchanged	€ 1,651 Land & buildings 2025: € 1,651 ▼ 17% vs 2024 (€ 1,991) Unchanged	▼ 17%
Retained profit	€ -114 Retained profit 2022: € -114 First fiscal year in the series	€ -3,576 Retained profit 2023: € -3,576 ▼ € 3,462 vs 2022 (€ -114) Unfavourable step	€ 9,200 Retained profit 2024: € 9,200 ▲ € 12,776 vs 2023 (€ -3,576) Favourable step	€ 3,369 Retained profit 2025: € 3,369 ▼ 63% vs 2024 (€ 9,200) Unfavourable step	▼ 63%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 0 Dividend 2023: € 0 Unchanged (€ 0) Unchanged	€ 10,000 Dividend 2024: € 10,000 Unchanged (€ 0) Unchanged	€ 20,000 Dividend 2025: € 20,000 ▲ 100% vs 2024 (€ 10,000) Unchanged	▲ 100%
Bank debt	€ 96,681 Bank debt 2022: € 96,681 First fiscal year in the series	€ 74,992 Bank debt 2023: € 74,992 ▼ 22% vs 2022 (€ 96,681) Favourable step	€ 56,288 Bank debt 2024: € 56,288 ▼ 25% vs 2023 (€ 74,992) Favourable step	€ 40,645 Bank debt 2025: € 40,645 ▼ 28% vs 2024 (€ 56,288) Favourable step	▼ 28%
Balance sheet total	€ 176,958 Balance sheet total 2022: € 176,958 First fiscal year in the series	€ 149,875 Balance sheet total 2023: € 149,875 ▼ 15% vs 2022 (€ 176,958) Unchanged	€ 146,322 Balance sheet total 2024: € 146,322 ▼ 2% vs 2023 (€ 149,875) Unchanged	€ 130,245 Balance sheet total 2025: € 130,245 ▼ 11% vs 2024 (€ 146,322) Unchanged	▼ 11%

Key figures of MEDLINX LINA, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to MEDLINX LINA?

What happened at MEDLINX LINA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 25, 2026 New annual accounts for financial year 2025: profit of € 14,170 (▼ 38% vs 2024). Source: NBB ↗
2023 SAID BAZGOURI became a director. NBB
May 23, 2018 New establishment in Schaarbeek. KBO
May 23, 2018 Start of the company according to the CBE. KBO

In short

From € 1,210 loss in 2022 to € 14,170 profit in 2025.

Paid € 14,958 in corporate taxes since 2022.

Best year ever: 2024, with € 22,776 profit.

Paid out € 30,000 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at MEDLINX LINA? We notify you, reason included.

Follow MEDLINX LINA

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

SAID BAZGOURI

MEDLINX LINA

Behind MEDLINX LINA is SAID BAZGOURI.

See the full network in the app

Directors

According to the 2025 annual accounts

SAID BAZGOURI

Director

since 2023

Establishments

Establishment units

Physical locations of this company

Registered office

Anatole Francestraat 100

1030 Schaarbeek

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0696.701.906
VAT number: BE 0696.701.906
Registered office: Anatole Francestraat 100, 1030 Schaarbeek
Names & denominations: MEDLINX LINA
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 23 May 2018
Peppol: Active · Active since 26 Nov 2025
Activities · NACE: Detailhandel in farmaceutische producten

View on CBE Public ↗ Annual accounts (NBB) ↗